Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
M2i Group is a French life sciences and industrial biotechnology company focused on the design, synthesis, formulation, and manufacturing of complex molecules for biocontrol, animal health, and selected healthcare applications. The company is best known for pheromone-based crop protection products that aim to replace or reduce conventional chemical pesticides, and it also offers custom synthesis, API/intermediate development, and cGMP manufacturing services. M2i operates an integrated model spanning R&D, scale-up, formulation, regulatory support, and commercial production in France. In agriculture, its products are already commercialized internationally, including through a strategic distribution partnership with Bayer. The company also maintains healthcare and veterinary capabilities through its pharma and fine chemistry activities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on M2i Group.